Opioid manufacturers have suffered a number of setbacks over the last several weeks. The FDA asked Endo Pharmaceuticals, in June, to stop the sale of Opana ER, an “extended-release” opioid pain reliever (OPR). If not, the agency promised it would no longer approve the drug. Endo indicated it would fully consider the request before acting. Then on … [Read more...]
Decreased Sex Drive in Men: Is Your Low Libido Just Normal?
A decreased sex drive (libido) in men is often a symptom of conditions like low testosterone related to aging, but could also be side effects associated with certain medications. Below is a list of diseases and conditions associated with symptoms like decreased sex drive, as well as a list of medications related to similar side effects. We are not … [Read more...]
Op-Ed By Larry Golbom – Addiction: The FDA and OxyContin
This is an editorial written by Larry Golbom of Prescription Addiction Radio. All viewpoints are welcome here at US Recall News. If you would like to write an editorial response please use the comment section below or contact us with your proposal. FDA: Please Stop Oxycontin! By Larry Golbom: In February 2009, the FDA announced that they would … [Read more...]
The Modern Marketing of Pain
This is a guest editorial post written by our newest contributor, Larry Golbom R.Ph MBA of the Prescription Addiction Radio show. We encourage comments from all viewpoints in this discussion. How The FDA Has Failed the US Since the Introduction of Oxycontin Compassion is a marvelous human trait. We read of disasters and human tragedy on a … [Read more...]
Modern Pain Killers: Biggest Medical Hoax in Last 100 Years
This is a guest editorial post written by our newest contributor, Larry Golbom R.Ph MBA of the Prescription Addiction Radio show. An Open Letter to the Legal Community Regarding the Overmarketing of Pain Killers by Pharmaceutical Companies Acting as Common Drug Dealers Prior to being named pain killers, the opium derived drugs were referred to as … [Read more...]
Recent Comments